Resources

What are MGM-15 and MGM-16?

Educational information — general and non-clinical, not peer experience and not medical advice.

If you're here because a product you used turned out to contain one of these instead of (or alongside) 7-OH, you're not behind — this is genuinely new territory, and confusion about it is normal.

What they actually are

MGM-15 and MGM-16 are lab-modified versions of 7-hydroxymitragynine — they don't occur naturally in the kratom plant the way trace amounts of 7-OH itself do. MGM-15 is commonly described as a dihydro version of 7-OH; MGM-16 is a further-modified, reportedly more potent version. Both are still sold in some markets as "kratom extract" products, even though they're semi-synthetic compounds engineered in a lab, not something you'd get from the plant itself.

The practical part: if a product doesn't clearly say what's in it, you may not actually know whether you were using 7-OH, MGM-15, MGM-16, or a mix — and that's not a knowledge gap you created, it's a labeling problem in this market. Find your room regardless of which one it was; withdrawal support here isn't gated on knowing the exact compound.

Why this matters for withdrawal

All three act on the same opioid receptors, and the newer, more modified compounds are generally reported as more potent, not less — so there's no reason to assume switching to one because it was marketed as an "alternative" means an easier stop. See Is 7-OH an opioid? for why this whole family tends to produce an opiate-like withdrawal pattern.

The regulatory status, as of this writing

In 2026 the DEA moved to temporarily schedule dihydro-7-hydroxymitragynine (MGM-15) alongside 7-OH, with a related action covering MGM-16 and other synthesized derivatives. This is changing quickly and varies further by state — see News & legal updates for what's current, and treat anything written here about legal status as likely dated by the time you read it.

← Back to Resources